Experimental models to study development and function of the human immune system in vivo

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2053-2058

  Legrand, Nicolas ^a   Weijer, Kees ^a,b   Spits, Hergen ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; INTERLEUKIN 15; INTERLEUKIN 3; INTERLEUKIN 7; MAJOR HISTOCOMPATIBILITY ANTIGEN; STEM CELL FACTOR; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; BONE MARROW CELL; CELLULAR IMMUNITY; EXPERIMENTAL MODEL; FETUS LIVER; FLOW CYTOMETRY; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SHORT SURVEY; T LYMPHOCYTE; THYMUS; UMBILICAL CORD BLOOD; XENOTRANSPLANTATION;

EID: 32044454701     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2053     Document Type: Short Survey

References (59)

1. McCune, J. M. 1997. Animal models of HIV-1 disease. Science 278: 2141-2142.
2. Bosma, G. C., R. P. Custer, and M. J. Bosma. 1983. A severe combined immunodeficiency mutation in the mouse. Nature 301: 527-530.
3. Kirchgessner, C. U., C. K. Patil, J. W. Evans, C. A. Cuomo, L. M. Fried, T. Carter, M. A. Oettinger, and J. M. Brown. 1995. DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect. Science 267: 1178-1183.
4. Mosier, D. E., R. J. Gulizia, S. M. Baird, and D. B. Wilson. 1988. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 335: 256-259.
5. McCune, J. M., R. Namikawa, H. Kaneshima, L. D. Shultz, M. Lieberman, and I. L. Weissman. 1988. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 241: 1632-1639.
6. Krowka, J. F., S. Sarin, R. Namikawa, J. M. McCune, and H. Kaneshima. 1991. Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent. J. Immunol. 146: 3751-3756.
7. Lapidot, T., F. Pflumio, M. Doedens, B. Murdoch, D. E. Williams, and J. E. Dick. 1992. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255: 1137-1141.
8. Vormoor, J., T. Lapidot, F. Pflumio, G. Risdon, B. Patterson, H. E. Broxmeyer, and J. E. Dick. 1994. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 83: 2489-2497.
9. Kamel-Reid, S., and J. E. Dick. 1988. Engraftment of immune-deficient mice with human hematopoietic stem cells. Science 242: 1706-1709.
10. Greiner, D. L., R. A. Hesselton, and L. D. Shultz. 1998. SCID mouse models of human stem cell engraftment. Stem Cells 16: 166-177.
11. Hesselton, R. M., D. L. Greiner, J. P. Mordes, T. V. Rajan, J. L. Sullivan, and L. D. Shultz. 1995. High levels of human peripheral blood mononuclear cell engraftment and enhanced susceptibility to human immunodeficiency virus type I infection in NOD/LtSz-scid/scid mice. J. Infect. Dis. 172: 974-982.
12. Larochelle, A., J. Vormoor, H. Hanenberg, J. C. Wang, M. Bhatia, T. Lapidot, T. Moritz, B. Murdoch, X. L. Xiao, I. Kato, D. A. Williams, and J. E. Dick. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2: 1329-1337.
13. Ogasawara, K., J. A. Hamerman, H. Hsin, S. Chikuma, H. Bour-Jordan, T. Chen, T. Pertel, C. Carnaud, J. A. Bluestone, and L. L. Lanier. 2003. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18: 41-51.
14. Baxter, A. G., and A. Cooke. 1993. Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42: 1574-1578.
15. Shultz, L. D., P. A. Schweitzer, S. W. Christianson, B. Gott, I. B. Schweitzer, B. Tennent, S. McKenna, L. Mobraaten, T. V. Rajan, D. L. Greiner, et al. 1995. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J. Immunol. 154: 180-191.
16. Prochazka, M., H. R. Gaskins, L. D. Shultz, and E. H. Leiter. 1992. The nonobese diabetic scid mouse: model for spontaneous thymomagenesis associated with immunodeficiency. Proc. Natl. Acad. Sci. USA 89: 3290-3294.
17. + cord blood cells. J. Exp. Med. 189: 1601-1610.
18. + cells. Blood 99: 1620-1626.
19. cnull mice model. Blood 102: 873-880.
20. 2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 95: 3102-3105.
21. Liao, N. S., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253: 199-202.
22. DiSanto, J. P., W. Muller, D. Guy-Grand, A. Fischer, and K. Rajewsky. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc. Natl. Acad. Sci. USA 92: 377-381.
23. Coulombel, L. 2004. Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays. Oncogene 23: 7210-7222.
24. Dick, J. E. 1996. Normal and leukemic human stem cells assayed in SCID mice. Semin. Immunol. 8: 197-206.
25. - cells in cord blood and bone marrow. Blood 86: 3745-3753.
26. DiGiusto, D., S. Chen, J. Combs, S. Webb, R. Namikawa, A. Tsukamoto, B. P. Chen, and A. H. Galy. 1994. Human fetal bone marrow early progenitors for T, B, and myeloid cells are found exclusively in the population expressing high levels of CD34. Blood 84: 421-432.
27. Bhatia, M., J. C. Wang, U. Kapp, D. Bonnet, and J. E. Dick. 1997. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. USA 94: 5320-5325.
28. 2 microglobulin-null mice. J. Clin. Invest. 107: 199-206.
29. + cord blood cells transplanted into NOD/SCID mice. Proc. Natl. Acad. Sci. USA 99: 413-418.
30. + cells. Exp. Hematol. 31: 551-558.
31. +-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 90: 85-96.
32. Ramirez, M., G. A. Rottman, L. D. Shultz, and C. I. Civin. 1998. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Exp. Hematol. 26: 332-344.
33. Rossi, M. I., K. L. Medina, K. Garrett, G. Kolar, P. C. Comp, L. D. Shultz, J. D. Capra, P. Wilson, A. Schipul, and P. W. Kincade. 2001. Relatively normal human lymphopoiesis but rapid turnover of newly formed B cells in transplanted nonobese diabetic/SCID mice. J. Immunol. 167: 3033-3042.
34. Dao, M. A., K. A. Pepper, and J. A. Nolta. 1997. Long-term cytokine production from engineered primary human stromal cells influences human hematopoiesis in an in vivo xenograft model. Stem Cells 15: 443-454.
35. Nonoyama, S., F. O. Smith, I. D. Bernstein, and H. D. Ochs. 1993. Strain-dependent leakiness of mice with severe combined immune deficiency. J. Immunol. 150: 3817-3824.
36. Colucci, H., C. Soudais, E. Rosmaraki, L. Vanes, V. L. Tybulewicz, and J. P. Di Santo. 1999. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. J. Immunol. 162: 2761-2765.
37. Weijer, K., C. H. Uittenbogaart, A. Voordouw, F. Couwenberg, J. Seppen, B. Blom, F. A. Vyth-Dreese, and H. Spits. 2002. Intrathymic and extrathymic development of human plasmacytoid dendritic cell precursors in vivo. Blood 99: 2752-2759.
38. Mazurier, F., A. Fontanellas, S. Salesse, L. Taine, S. Landriau, F. Moreau-Gaudry, J. Reiffers, B. Peault, J. P. Di Santo, and H. de Vernenil. 1999. A novel immunodeficient mouse model-RAG2 X common cytokine receptor γ chain double mutants-requiring exogenous cytokine administration for human hematopoietic stem cell engraftment. J. Interferon Cytokine Res. 19: 533-541.
39. Traggiai, E., L. Chicha, L. Mazzucchelli, L. Bronz, J. C. Piffaretti, A. Lanzavecchia, and M. G. Manz. 2004. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304: 104-107.
40. -/- mice: functional inactivation of p53 in developing T cells. Blood 104: 3886-3893.
41. -/- mice. Ann. NY Acad. Sci. 1044: 236-243.
42. Ishikawa, F., M. Yasukawa, B. Lyons, S. Yoshida, T. Miyamoto, G. Yoshimoto, T. Watanabe, K. Akashi, L. D. Shultz, and M. Harada. 2005. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chain null mice. Blood 106: 1565-1573.
43. + CD38. Leukemia 17: 960-964.
44. c double-knockout mice after treatment with CL2MDP liposomes. Exp. Hematol. 32: 1118-1125.
45. van Rooijen, N., A. Sanders, and T. K. van den Berg. 1996. Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. J. Immunol. Methods 193: 93-99.
46. -/- double-mutant mice. Blood 102:2522-2531.
47. Tacke, M., G. Hanke, T. Hanke, and T. Hunig. 1997. CD28-mediated induction of proliferation in resting T cells in vitro and in vivo without engagement of the T cell receptor: evidence for functionally distinct forms of CD28. Eur. J. Immunol. 27: 239-247.
48. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur. J. Immunol. 31: 1247-1254.
49. Zinkernagel, R. M., and A. Althage. 1999. On the role of thymic epithelium vs. bone marrow-derived cells in repertoire selection of T cells. Proc. Natl. Acad. Sci. USA 96: 8092-8097.
50. + thymocytes and identification of thymic emigrants. J. Immunol. 155: 1862-1872.
51. Siegal, F. P., N. Kadowaki, M. Shodell, P. A. Fitzgerald-Bocarsly, K. Shah, S. Ho, S. Antonenko, and Y. J. Liu. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284: 1835-1837.
52. Schotte, R., M. Nagasawa, K. Weijer, H. Spits, and B. Blom. 2004. The ETS transcription factor Spi-B is required for human plasmacytoid dendritic cell development. J. Exp. Med. 200: 1503-1509.
53. Cupedo, T., and R. E. Mebius. 2005. Cellular interactions in lymph node development. J. Immunol. 174: 21-25.
54. Suzuki, H., T. M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. Simard, P. S. Ohashi, H. Griesser, et al. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 268: 1472-1476.
55. Shultz, L. D., B. L. Lyons, L. M. Burzenski, B. Gott, X. Chen, S. Chaleff, M. Kotb, S. D. Gillies, M. King, J. Mangada, D. L. Greiner, and R. Handgretinger. 2005. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rγ null mice engrafted with mobilized human hemopoietic stem cells. J. Immunol. 174: 6477-6489.
56. Namikawa, R., K. N. Weilbaecher, H. Kaneshima, E. J. Yee, and J. M. McCune. 1990. Long-term human hematopoiesis in the SCID-hu mouse. J. Exp. Med. 172: 1055-1063.
57. Yahata, T., K. Ando, T. Sato, H. Miyatake, Y. Nakamura, Y. Muguruma, S. Kato, and T. Hotta. 2003. A highly sensitive strategy for SCID-repopulating cell assay by direct injection of primitive human hematopoietic cells into NOD/SCID mice bone marrow. Blood 101: 2905-2913.
58. c(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100: 3175-3182.
59. + cells in nonobese diabetic/Shi-scid, IL-2 receptor γ null mice. J. Immunol. 169: 204-209.